TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship

Am J Physiol. 1998 Aug;275(2):R502-8. doi: 10.1152/ajpregu.1998.275.2.R502.

Abstract

Exogenous tumor necrosis factor-alpha (TNF-alpha) induces delayed myocardial depression in vivo but promotes rapid myocardial depression in vitro. The temporal relationship between endogenous TNF-alpha and endotoxemic myocardial depression is unclear, and the role of TNF-alpha in this myocardial disorder remains controversial. Using a rat model of endotoxemia not complicated by shock, we sought to determine 1) the temporal relationship of changes in circulating and myocardial TNF-alpha with myocardial depression, 2) the influences of protein synthesis inhibition or immunosuppression on TNF-alpha production and myocardial depression, and 3) the influence of neutralization of TNF-alpha on myocardial depression. Rats were treated with lipopolysaccharide (LPS, 0.5 mg/kg ip). Circulating and myocardial TNF-alpha increased at 1 and 2 h, whereas myocardial contractility was depressed at 4 and 6 h. Pretreatment with cycloheximide or dexamethasone abolished the increase in circulating and myocardial TNF-alpha and preserved myocardial contractile function. Similarly, treatment with TNF binding protein immediately after LPS prevented myocardial depression. We conclude that endogenous TNF-alpha mediates delayed myocardial depression in endotoxemic rats and that inhibition of TNF-alpha production or neutralization of TNF-alpha preserves myocardial contractile function in endotoxemia.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Analysis of Variance
  • Animals
  • Cycloheximide / pharmacology
  • Endotoxemia / physiopathology*
  • Heart / drug effects
  • Heart / physiology
  • Heart / physiopathology*
  • In Vitro Techniques
  • Lipopolysaccharides / toxicity
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Salmonella typhimurium
  • Time Factors
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Cycloheximide